September 26, 2014

As part of its new Women’s Wellness initiative, Schnucks Pharmacies has announced that four different oral breast cancer medications (Letrozole, Megestrol, Anastrozole and Tamoxifen) will be available for $9 with a valid prescription.

December 17, 2013

Greenstone has launched a version of a drug used to treat fungal infections, the company said.

December 10, 2013

Nearly all patients taking an experimental treatment for hepatitis C developed by AbbVie were cured, the drug maker said Tuesday.

January 17, 2013

Boehringer Ingelheim Pharmaceuticals has enrolled the first patients in its late-stage trial of a treatment for hepatitis C, the drug maker said Thursday.

January 2, 2013

Mylan announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug applications for rizatriptan benzoate orally disintegrating tablets and rizatriptan benzoate tablets, generic versions of Merck's Maxalt MLT Tablets and Maxalt Tablets.

June 14, 2012

Kadmon Pharmaceuticals earlier this month announced that it has launched a new 600 mg/day dose pack of Ribasphere RibaPak (ribavirin, USP), Kadmon's proprietary ribavirin regimen available in a daily, two-pill compliance package for enhanced therapy adherence.

April 20, 2012

Merck is testing two means of treating patients with chronic hepatitis C for anemia, a common side effect of certain treatments for the viral infection, the drug maker said.

December 19, 2011

The Food and Drug Administration has approved a drug made by Sandoz for treating yeast and other fungal infections.

February 15, 2011

Mylan has launched a generic drug for fungal infections, the company said Tuesday.

October 31, 2010

Drug makers Valeant Pharmaceuticals International and Kadmon Pharmaceuticals will collaborate to develop antiviral drugs for...

August 11, 2010

An investigational drug made by Pharmasset for treating hepatitis C will get expedited review from...

August 8, 2010

An investigational drug in late-stage clinical trials increased the cure rate in patients with hepatitis...

July 18, 2010

Eisai's new drug application for a drug designed as an adjunctive treatment of seizures associated...

June 30, 2010

Anglo-Swedish drug maker AstraZeneca has created a savings card for users of one of its...

March 17, 2010

The Food and Drug Administration has approved a generic anxiety drug made by Actavis, the...